Boca Andreea Nicoleta, Ilies Roxana Flavia, Saccomanno Jacopo, Pop Raluca, Vesa Stefan, Tataru Alexandru Dumitru, Buzoianu Anca Dana
Department of Pharmacology, Toxicology and Clinical Pharmacology, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
Faculty of Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Exp Ther Med. 2019 Feb;17(2):1020-1023. doi: 10.3892/etm.2018.6983. Epub 2018 Nov 16.
Psoriasis is one of the most common chronic dermatological conditions, with a strong impact on patients' quality of life. Currently, psoriasis benefits from conventional therapy with a high rate of adverse effects and an increase in non-compliance and self-medication of patients. As such, there is a need to pinpoint low-adverse effects and accessible remedies for this condition. Our single-blind, placebo-controlled study assessed the effect of sea buckthorn extract on psoriasis lesions in previously untreated patients. Our results showed an improvement in Psoriasis Area Severity Index (PASI) scores and in Dermatology Life Quality Index (DLQI) scores when compared to the baseline values, as well as at the 4- and 8-week time marks for the lesions treated with sea buckthorn extract. By contrast, the measurements for the placebo treated lesions showed no alteration at the 4-week mark, and significant worsening at the end of the trial. These findings provide a solid, optimistic base for the in-depth research of sea buckthorn as an adjuvant or a component in psoriasis care protocols.
银屑病是最常见的慢性皮肤病之一,对患者的生活质量有很大影响。目前,银屑病的传统治疗存在较高的不良反应发生率,患者的依从性降低且自我用药情况增多。因此,需要找到针对这种疾病的低不良反应且易于获得的治疗方法。我们的单盲、安慰剂对照研究评估了沙棘提取物对未经治疗的患者银屑病皮损的影响。我们的结果显示,与基线值相比,以及在用沙棘提取物治疗的皮损在第4周和第8周时,银屑病面积和严重程度指数(PASI)评分以及皮肤病生活质量指数(DLQI)评分均有所改善。相比之下,安慰剂治疗皮损的测量结果在第4周时没有变化,在试验结束时显著恶化。这些发现为深入研究沙棘作为银屑病护理方案中的辅助药物或成分提供了坚实、乐观的基础。